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Editorial on the Research Topic
Neutrophil-Mediated Skin Diseases: Immunology and Genetics
Neutrophils are involved in the effector phase of the host defense against micro-organisms
and have a major role in the innate immune response but they also act in the modulation
of the adaptive immunity as well as in orchestrating the response of the immune system to
other triggers such as severe injury and trauma (Mortaz et al.). The deregulation of neutrophil
function and their hyperactivity can lead to inflammation and tissue damage as seen in
neutrophilic dermatoses that are a group of diseases due to accumulation of neutrophils in the
skin and less frequently in internal organs (Marzano et al.). The systemic involvement, which
may be sometimes severe, has led to coining the term “neutrophilic diseases.” The prototype
of neutrophilic diseases are pyoderma gangrenosum and Sweet’s syndrome (Marzano et al.;
Heath and Ortega-Loayza) but some authors suggest to include hidradenitis suppurativa as
well (Tricarico et al.; Vossen et al.; Frew), though there is no full agreement on this point;
for all these entities an important autoinflammatory component has been demonstrated in
their pathogenesis. Moreover, the spectrum of neutrophilic diseases is broad; it comprises
truly systemic diseases such as Behçet’s disease (Leccese and Alpsoy), but also psoriasis where
neutrophils play an important role in the pathophysiology (Le et al.; Wannick et al.) or the
inflammatory immunological response of leprosy (Schmitz et al.). The present issue is focused
on the interplay between immunology and genetics in neutrophil-mediated diseases, highlighting
the close links with the group of autoinflammatory diseases. The latter are characterized by
recurrent episodes of sterile inflammation in the affected organs with neutrophils involved as
leading cells, and are due to mutations in genes regulating the innate immunity. The recognition
of several monogenic diseases which can present with neutrophilic skin diseases, such as
CAPS (cryopyrin-associated periodic syndromes), DIRA (deficiency of IL-1 receptor antagonist),
DITRA (deficiency of IL-36 receptor antagonist), and PAPA (pyogenic sterile arthritis, pyoderma
gangrenosum, acne), has led to an improved understanding of the possible mechanisms of
polygenic non-mendelian inherited neutrophilic skin diseases (Marzano et al.; Heath and
Ortega-Loayza; Tricarico et al.; Vossen et al.). An increasing body of evidence supports the
role of pro-inflammatory cytokines like interleukin (IL)-1-beta, IL-17, and tumor necrosis
factor (TNF)-alpha in the pathophysiology of neutrophilic diseases similarly to classic
monogenic autoinflammatory diseases, suggesting common physiopathological mechanisms.
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Moreover, mutations of several genes involved in
autoinflammatory diseases are likely to play a role in the
pathogenesis of sporadic neutrophilic diseases, giving rise to
regarding them as a spectrum of polygenic autoinflammatory
conditions (Marzano et al.; Heath and Ortega-Loayza; Tricarico
et al.; Vossen et al.). Indeed, mutations of PSTPIP1 (proline-
serine-threonine phosphatase interacting protein 1), the
gene involved in PAPA, as well as of a number of other
genes involved in classic autoinflammatory diseases have
been demonstrated in both isolated and syndromic forms of
pyoderma gangrenosum, whose prototype is PASH (pyoderma
gangrenosum, acne, suppurative hidradenitis), as well as in
neutrophilic diseases in general. At present, classic regimens such
as systemic glucocorticosteroids and immunosuppressants are
the mainstay of treatment while biologic drugs are reserved for
refractory cases. We can thus hope that the precise elucidation
of the immunology and genetics of neutrophil-mediated
diseases will pave the way to pathogenesis-driven
treatments and the development of new drugs specifically
targeting the inflammatory pathways involved in
those entities.
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